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The objective of this field study was to compare the udder health status as well as the clinical mastitis
rate during the first 100 d of lactation in cows that received long-acting dry cow antibiotic alone
(group AB) or in combination with an internal teat sealant (group AB+OS). The study was conducted
during a 9-month period and included 136 Holstein cows from 12 dairy farms in Hessia, Germany.
Between days 1 and 5 after calving a California mastitis test (CMT) was performed. Milk-samples were
collected for bacteriological culture before drying off, between days 6 and 14 and days 35 and 56 of
lactation. Additionally the cows were monitored for the occurrence of clinical mastitis events until
100 d post partum. Within the 12 herds cow-pairs were formed on the basis of age, milk yield and
SCC. A cow-pair consisted of one cow from group AB and one cow from group AB+OS. For statistical
analysis within every cow-pair one quarter that has been dried off with internal teat sealant and dry
cow antibiotic (group AB+OS) was compared with one quarter that has been dried off with dry cow
antibiotic (group AB) alone. As criterion for the matching process of udder quarters the
cytobacteriological udder health status before drying off was used. A total of 544 quarters (136
cows) were used in this analysis. In the first 5 d after calving, group AB had significantly more quarters
with a positive CMT reaction than group AB+OS (85 vs. 57; P<0·001), and in the first 100 d of
lactation, group AB had more quarters with clinical mastitis than group AB+OS (25 vs. 15; P=0·03).
In the time periods 6–14 and 35–56 d of lactation, there were fewer quarters in group AB+OS
populated with Corynebacterium spp. (days 6–14, P=0·05; days 35–56, P=0·02) and aesculin-
positive streptococci (days 35–56, P=0·02). The internal teat sealant was a promising tool for the
prevention of new intramammary infections (IMI) of dry cowswith environmental udder pathogens as
expressed during early lactation.
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The introduction of antibiotic dry cow treatment was an
important advance in the prevention of mastitis in dairy cows
(Dodd et al. 1969). The purpose of treating the udder with a
long-acting antibiotic at drying off is to eliminate existing
infection and to prevent new infection during the dry period
(Smith et al. 1966). Dry cow treatment has led to significant
advances in the control of udder pathogens (Berry et al.
2004; Bradley & Green, 2004; Godden et al. 2004). Despite
the wide use of dry cow antibiotic therapy, clinical mastitis
caused by environmental pathogens is still common in early
lactation (Bradley & Green, 2001b). The same authors
demonstrated that 52% of all clinical coliform mastitis in the
first 100 d in milk occurred in quarters that were infected
during the dry period (Bradley & Green, 2000). In a study
involving 480 lactating cows with 1920 udder quarters that
had received antibiotic dry cow treatment at the end of the*For correspondence; e-mail: Peter-Michael.Zschoeck@lhl.hessen.de
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previous lactation, up to 60% of clinical mastitis cases in
early lactation were the result of udder infections that
originated in the previous dry period (Green et al. 2002).
In another study, approximately half of the mastitis cases
in early lactation were caused by environmental mastitis
pathogens (Todhunter et al. 1995). These authors also noted
that the bovine mammary gland had a higher predisposition
to infection caused by environmental mastitis pathogens
toward the end of the dry period.
A keratin plug normally forms in the bovine teat canal
within a few days after the last milking and acts as a
mechanical barrier to ascending pathogens, particularly
environmental pathogens, which may cause intramammary
infection (IMI) in dry cows (Comalli et al. 1984; Dingwell
et al. 2003). However, many high-producing dairy cows fail
to form an adequate keratin plug or plug formation is delayed
during the dry period. Williamson et al. (1995) reported that
an adequate natural keratin plug is produced in only about
50% of dried-off cows and plug formation does not occur in
5% of the dried-off cows. The keratin plug is critical for
protection against IMI and the risk of IMI increases in
cows with impaired plug integrity (Bramley & Dodd, 1984;
Capuco et al. 1992). Another risk factor for IMI in dry cows
is a decrease in antibiotic efficacy toward the end of the
dry period (Smith et al. 1967a, b; Oliver et al. 1991). Most
dry cow antibiotics provide protective concentrations
for approximately 4–5 weeks, but not until the end of the
6–8-week dry period. The risk of IMI is increased 2–4 weeks
before calving, which coincides with the production of
colostrum (Neave et al. 1950; Natzke, 1981). Furthermore,
various stressors that affect a dairy cow during early lactation
may influence the colonization of pathogens during the dry
period, causing subclinical or clinical mastitis. A commer-
cial internal teat sealant called OrbeSeal® (Pfizer Animal
Health, Karlsruhe) was developed to support the function
of the naturally occurring keratin plug and protect the
mammary gland against new IMIs during the entire dry
period. This product is the only licensed internal teat
sealant in Germany at the moment and consists of a
heavy alkaline bismuth nitrate in a paraffin base with no
antibiotic. In this novel combined dry cow treatment, the
internal teat sealant is administered into the teat cistern after
the application of an antibiotic substance. The internal teat
seal remains at the distal end of the teat and seals it for up to
100 d (Woolford et al. 1998). After calving the sealant is
stripped out by hand.
The purpose of this field study was to investigate whether
the addition of a commercial internal teat sealant to routine
dry cow treatment is beneficial for udder health.
Materials and Methods
Selection of herds and cows
Twelve free-stall Holstein dairy herds in Hessia, Germany
that were members of the Hessian dairy recording system
and had a minimum of 70 cows with an average milk yield
of 8000 kg per standard lactation were included. A Hessian
cow reached an average milk yield of 7769 kg per standard
lactation in 2007 (HVL, 2008).
All cows that were dried off between July 2006 and
October 2006 on the involved farms and that fulfilled the
following criteria were included in the study. The cows did
not have clinical mastitis and had not received any antibiotic
treatment within 30 d of drying off. The projected dry period
varied from 35 to 90 d. The lactation numbers varied from
2 to 8, and the dry cows were housed together in free-stalls
or were kept on pasture during summer months. Three to
14 d before the expected calving date, the cows weremoved
to straw-bedded pens.
A total of 152 cows, which were dried off from July 2006
to October 2006 and calved from December 2006 to March
2007, were selected for the study.
Dry cow treatment
On the day of drying off, the entire udder was examined
clinically. Duplicate quarter foremilk samples were
collected aseptically according to the standards of the
International Dairy Federation (IDF) for determination of
somatic cell count (SCC) and bacteriological culture (IDF,
1981).
Within each of the 12 herds, the dry cowswere assigned to
one of the two treatment groups by an alternating procedure.
Every second cow that entered the milking parlour was
treated in all four quarters with a long-acting dry cow
antibiotic combined with the application of an internal teat
sealant (AB+OS; OrbeSeal®, Pfizer/ Karlsruhe). The other
cow of the pair was dried off with a long-acting dry cow
antibiotic of all four quarters (AB).
Antibiotic preparations used for dry cow treatment
included Benestermycin® (300000 IE benetamine penicillin+
100000 IE penethamate hydriodide+100mg framecytin
sulphate), Orbenin DC® (1·28 g benzathine cloxacillin)
and Nafpenzal T® (benzylpenicillin+dihydrostreptomycin
sulphate+nafcillin sodiummonohydrate). Only one of these
products was used within a herd, so that all cows within one
herd received the same active ingredient. The farms applied
those long-acting dry cow antibiotics they usually used in
their dry-off routine.
Early post-calving examinations
During the first 5 d after calving, each cow underwent
a California mastitis test (CMT; Bovivet® CMT, KRUUSE/
Denmark). The results of the CMT were scored in negative
(), trace (+), weakly positive (+), clearly positive (++) and
strongly positive (+++) reactions. A foremilk sample was
collected aseptically from each quarter once between days 6
and 14 and once between days 35 and 56 for bacteriological
culture and determination of SCC (IDF, 1981).
Clinical mastitis cases were monitored until 100 d after
calving according to former studies (Woolford et al. 1998;
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Bradley & Green, 2000; Huxley et al. 2002; Berry &
Hillerton, 2007; Newton et al. 2008).
Clinical mastitis was diagnosed when visible changes in
the milk (presence of sanies) occurred and was classified
as follows: grade 0 (no clinical mastitis), grade 1 (clinical
mastitis without generalized clinical signs), grade 2 (clinical
mastitis with generalized clinical signs like fever, toxaemia
and/or depression), grade 3 (peracute mastitis with severe
illness or death).
Laboratory examinations
The quarter milk samples were stored at 6–8 °C after
collection and transported to the laboratory for further
analysis on the same day. A somatic cell counter (Fossomatic
5000, Foss-Electric, Denmark) was used for the SCC
determinations. Bacteriological culture and differentiation
of the mastitis pathogens was carried out according to the
IDF standards (1981). Milk samples were warmed to room
temperature and 0·01 ml of milk was streaked onto bovine
blood agar (Merck AG, Darmstadt, Germany) supplemented
with 0·1% aesculin. Agar plates were incubated aerobically
at 37 °C and examined after 24 and 48 h. For biochemical
identification, isolates were subcultured on bovine blood
agar.
Additional SCC determinations
All the cows underwent regular SCC determinations through
the Hessian dairy recording system. For determination of the
whole SCC of the cows a somatic cell counter (Fossomatic
5500) was used.
Statistical analysis
The statistical unit for the analysis was a pair of two quarters
consisting of a quarter from group AB and a quarter from
group AB+OS. In a first step, pairs of cows within the same
herd, one from groupAB and one from groupAB+OS, with a
comparable composite SCC in the latest test before drying
off, lactation number and length of lactation at drying off
were formed. In a second step, pairs of quarters between
those cow pairs, one from a cow from group AB and one
from a cow from group AB+OS, with comparable SCC and
culture results at drying off were formed. So the matching
process was carried out only between cows/quarters
belonging to the same herd. Front quarters were only paired
with front quarters and back quarters were only paired with
back quarters. Furthermore only quarters were paired that
have been treated with the same long-acting dry cow
antibiotic substance (e.g. a quarter from group AB that was
dried of with Benestermycin® was compared with a quarter
from group AB+OS that was also dried off with
Benestermycin® and the internal teat sealant OrbeSeal®).
The statistical software package BMDP/Dynamic, Release
7.0 (Dixon, 1993) was used for the analysis of the data. If the
distribution of positive quantitative variables was skewed
to the right, logarithmic transformation was used to generate
a normal distribution, but antilogarithms were used for
presentation of the results. For this reason, SCC data are
transformed logarithmically in the analysis. A significance
level of α=0·05 was used. So a P-value less or equal to 0·05
was considered significant. The main dependent variables in
the statistical analysis of the study were, CMT result on days
1–5 post-calving, SCC and culture results on days 6–14 post-
calving and days 35–56 post-calving, SCC of composite
samples taken in the first, second and third month post-
calving and occurrence of clinical mastitis during the first
100 d of lactation.
A quarter that was affected by clinical mastitis more than
once during the study period was counted as only one
mastitis event.
Two-way analysis of variance with repeated measures
with the factors time and treatment was used to analyse the
independent variables ‘SCC test results of the Hessian dairy
recording system’ and ‘SCC test results of quarter samples’. In
an additional step, an analysis of covariance was used with
further independent variables (e.g. lactation number). The
Wilcoxon matched-pairs signed-ranks test was used to
analyse CMT results, culture results of quarter foremilk
samples and the occurrence of clinical mastitis. For the
analysis of the culture results of milk samples, the clinical
mastitis categories in groups AB and AB+OS at different
sampling times were also considered using the same method
with one-tailed alternative hypothesis stated.
Results
Database
Of 152 cows that entered the study at drying off, 136 cows
(544 quarters) remained in the study after calving. Three
cows had a dry period shorter than 10 d, 3 cows calved after
the end of the study period, and 1 cow was not pregnant.
The remaining 9 cows died while dry or shortly after calving
because of dystocia, milk fever or an injury. The two
Table 1. Lactation number and length of last lactation period, dry
period and milk yield (means) of cows of groups AB and AB+OS.
There were no significant differences (P>0·05) between the two
groups
Group
AB+OS† AB‡
Lactation number, mean value 3·3 3·0
Length of last lactation period, d 362·6 344,2
Length of dry period, d 51·5 51·5
Milk yield at drying-off, kg/cow per d 15·89 16·23
†Dry cow treatment using an antibiotic (Benestermycin®, Orbenin Extra® or
Nafpenzal®) and an internal teat seal (OrbeSeal®)
‡Dry cow treatment using an antibiotic (Benestermycin®, Orbenin Extra® or
Nafpenzal®)
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treatment groups did not differ with respect to lactation
number and length, milk yield and length of the dry period
(Table 1).
CMT
514 quarters (257 in each group) from 129 cows remained
for statistical analysis of the CMT results. A total of 30
quarters, including 15 that were paired with 15 affected
quarters, were excluded from statistical analysis 1–5 d post-
calving. Fifteen quarters were excluded because 6 cows had
1 blind teat each, 1 cow had grade 2 clinical mastitis (4),
1 cow had grade 1 mastitis in 1 quarter and was treated with
systemic antibiotics (4n) and another cowhad amild grade
1 clinical mastitis in 1 quarter.
In group AB+OS significant more CMT-negative quarters
could be observed than in group AB (200 vs. 172; P <0·001).
CMT-positive quarters showed reactions ranging from + to
+++.
Laboratory examinations
A total of 26 quarters, including 13 that were paired with the
13 affected quarters, were excluded from analysis, resulting
in 518 quarters (259 in each group) from 65 cows. Thirteen
quarters could not be evaluated because 6 cows had
1 blind teat each, 4 foremilk samples were contaminated,
2 cowswith grade 2 clinical mastitis in 1 quarter were treated
with an intramammary antibiotic, and 1 quarter yielded no
milk.
The number of quarters that were eliminated from the SCC
of quarter foremilk samples was nearly similar to those in the
analysis of bacteriological culture results, but slightly lower
because the SCC could be determined in samples that were
contaminated or in samples from udders with an antibiotic
therapy. Contamination is the microbial pollution of objects,
samples for investigation and parts of the body with
microorganisms from the animate and inanimate environ-
ment without any adhesion or proliferation of the microor-
ganisms.
According the SCC quarter foremilk samples in both
treatment groups there was a decrease (P <0·001) in the SCC
from drying off to the two test periods at days 6–14 and days
35–56 (Table 2). There was no difference between the
geometric means of the cell counts of the two groups
(P=0·36).
According the bacteriological culture 6–14 d post partum
in group AB more quarter samples yielded growth of
Corynebacterium spp. than samples in group AB+OS
(24 vs. 14; P=0·05). But there was no difference between
the treatment groupswith respect to positive cultures of other
mastitis pathogens (Table 3).
Table 2. Somatic cell count of quarter foremilk samples at different time points in the study (geometric means±SD, number of cells/ml and
geometric standard deviation (=dispersion factor); n, number of quarters)
Time point
Somatic cell count†
Group AB+OS‡ Group AB§
At drying off 133000; 4·74 (n=270) 114000; 4·28 (n=268)
Between lactation days 6 and 14 37000; 4·06 (n=270) 32000; 4·14 (n=266)
Between lactation days 35 and 56 23000; 4·84 (n=269) 24000; 5·90 (n=256)
†SCC numbers did not differ between groups (P=0·37)
‡Dry cow treatment using an antibiotic (Benestermycin®, Orbenin Extra® or Nafpenzal®) and an internal teat seal (OrbeSeal®)
§Dry cow treatment using an antibiotic (Benestermycin®, Orbenin Extra® or Nafpenzal®)
Table 3.Number of quarters with isolates of intramammary pathogens in groups AB and AB+OS between days 6 and 14 and days 35 and 56
of lactation
Pathogen
Days 6–14 (n=259) Days 35–56 (n=244)
Group AB+OS† Group AB‡ Group AB+OS† Group AB‡
Corynebacterium spp. 14a 24a 35b 53b
Coagulase-negative staphylococci 25 34 16 23
Esculin-positive streptococci 5 3 2 9
Staphylococcus aureus 0 4 0 2
Streptococcus dysgalactiae 0 0 1 1
Streptococcus agalactiae 0 0 0 0
Escherichia coli/other coliforms 3 7 1 5
Other pathogens (Proteus spp., Bacillus spp. etc.) 7 8 11 7
†Dry cow treatment using an antibiotic (Benestermycin®, Orbenin Extra® or Nafpenzal®) and an internal teat seal (OrbeSeal®)
‡Dry cow treatment using an antibiotic (Benestermycin®, Orbenin Extra® or Nafpenzal®)
a,bWithin rows numbers with the same superscript differ (a, P=0·0471; b, P=0·0161)
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Regarding the bacteriological culture 35–56 d post partum
a total of 56 quarters, including 28 that were paired with the
28 affected quarters, were excluded from analysis, resulting
in 488 quarters (244 in each group) from 61 cows (Table 3).
Twenty-eight quarters could not be evaluated because
6 cows had 1 blind teat each (6n), 8 foremilk samples
were contaminated (8n), 3 cows were culled (arthritis,
abomasal displacement;12n) and 2 cows had received an
antibiotic treatment because of a grade 2 clinical mastitis in
one quarter (2n). In group AB also more quarter samples
significantly yielded growth of Corynebacterium spp.
(53 vs. 35; P=0·02). Additionally a difference between the
two treatment groups could be observed in aesculin-positive
streptococci (9 vs. 2; P=0·02).
Additional SCC determination
The two treatment groups did not differ with respect to
regular determination of SCC during the 3 months before
calving and the 3 months after (P=0·28). In both groups,
there was a significant decrease in SCC from the last pre-
calving test to the first post-calving test (P=0·0001). Older
cows had significantly higher SCC results than younger
animals.
Clinical mastitis events
During the dry period, a total of 6 quarters (including 3
normal paired quarters) were excluded from analysis
because of incomplete data sets, resulting in 538 quarters
(269 in each group) in the analysis. During the dry period,
there were no cases of clinical mastitis. After calving, a total
of 40 quarters were affected by clinical mastitis, 25 in Group
AB and 15 in group AB+OS (Table 4); this difference was
significant (P=0·03). There were 7 quarters with grade
2 clinical mastitis in groupAB and 1 in groupAB+OS. Grade
3 clinical mastitis did not occur. An investigation concerning
the question which pathogen caused the mastitis was not
conducted.
Discussion
Compared with previous studies (Godden et al. 2003; Berry
& Hillerton, 2007) the present field study used a larger
number of herds, a longer investigation period and matched
pairs of quarters within herds for statistical evaluation. The
present study was designed as a follow-up to studies by
Godden et al. (2003) and Berry & Hillerton (2007), who also
compared conventional dry cow treatment with dry cow
treatment that included an internal teat seal. Two commer-
cial dairy herds in the USAwere used in the former study and
a research herd in the latter. The trial design as well as the
statistical evaluation of the current field-study differs from
these former studies. We used the internal teat sealant in
a larger number of dairy farms under practical conditions
to investigate its effect under different management con-
ditions. In accordance with the field-study aspect of our
investigation, the dry cow antibiotics routinely used in
each herd were not changed, so that the farms used different
antibiotic agents for drying off. Furthermore, compared
with previous studies on the internal teat sealant in which
udder health was monitored during the first week of
lactation, we extended the period of monitoring and
sampling to between 35 and 56 d in milk (DIM). Every cow
was monitored concerning the occurrence of clinical
mastitis cases until the 100 DIM according to former studies
by Bradley & Green (2000), Huxley et al. (2002), Berry &
Hillerton (2007) and Newton et al. (2008). Especially
Bradley & Green (2000) showed that 52% of all clinical
coliform mastitis cases in the first 100 d after calving have
their origin in the dry period.
A further unique feature of the present study was the
statistical analysis of data, which was based on matched
pairs between udder quarters of cows that belonged to the
same herd. This guaranteed the comparison of udder
quarters that had received the same dry cowantibiotic agent.
The use of the internal teat sealant alone or in combination
with dry cow antibiotics is a relatively new management
technique in Germany. In previous studies (Berry &
Hillerton, 2002a; Belke et al. 2004; Newton et al. 2008)
the rate of IMIs acquired during the dry period and/or the
clinical mastitis rate was significantly lower in cows that
were treated with antibiotics and the teat sealant compared
with cows that did not receive dry cow treatment or were
treated with antibiotics alone. The present study yielded
results similar to those of Godden et al. (2003), but in
contrast to that study, our treatment was applied at the cow
level rather than the quarter level because within cows, all
quarters received the same treatment.
Of the various factors that affect udder health, the herd
effect plays an important role. Every farm has an individual
strategy of managing its dairy herd in the field of feeding,
housing and dry cowmanagement, which has to be seen as a
factor of influence on the state of health and here especially
on the udder health of the cow. Green et al. (2007) showed
that herd management factors (hygiene, dry cow therapy,
management of the early and late dry period, calving area,
etc.) were associated with an increased rate of clinical
mastitis in the following lactation. To eliminate the herd
effect on the outcome of our study, a so-called matched
pairs design was used. Pairs of cows, consisting of one
Table 4. Number of quarters (%) affected by clinical mastitis in the
first 100 d of lactation in two treatment groups (AB+OS/AB)
Group AB+OS† Group AB‡
Grade 1 14 (5·2%) 18 (6·7%)
Grade 2 1 (0·4%) 7 (2·6%)
Total 15a (5·6%) 25a (9·3%)
†Dry cow treatment using an antibiotic (Benestermycin®, Orbenin Extra® or
Nafpenzal®) and an internal teat seal (OrbeSeal®)
‡Dry cow treatment using an antibiotic (Benestermycin®, Orbenin Extra® or
Nafpenzal®)
aP=0·0257
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cow from each treatment group, were formed within herds
on the basis of age, milk yield and SCC. Only cows were
compared concerning the development of their udder health
status in the test period that belonged to the same herd so
that equal basic conditions for each cow pair could be
guaranteed. Cow-individual factors—such as the cleanliness
of teats—were not taken into consideration because the
present study aimed at testing the additional effect of
the internal teat seal under practical conditions unaffected
by the hygiene standard of the farms. For analysis, pairs of
quarters (1 quarter from each treatment group) were then
formed on the basis of comparable cytobacteriological status
at the day of dry-off. This allowed elimination of the
confounders for herd effect and the effect of the particular
dry cow antibiotic used because all cows within a herd were
treatedwith the same antibiotic. The paired quarters from the
paired cows were the cases to be analysed statistically. At
the beginning of the study, the 2 treatment groups did
not differ with respect to various variables relating to udder
health (Table 1). The results of the cytobacteriological
examinations of the quarter foremilk samples at the day of
dry-off were used as parameter for finding quarter pairs with
an equal starting situation at that time.
The numbers of quarters that could be evaluated at the
different time points of evaluation varied. This was
unavoidable and resulted from the elimination of cows
from herds because of illness and accidents.
All cows underwent a CMT within the first 5 d after
calving to monitor udder health. According to a study of
Maunsell et al. (1999) results of the CMT with colostral
quarter milk samples were associated significantly with the
IMI status after calving. Sargeant et al. (2001) and Hamann
et al. (2004) describe CMT as a screening method to detect
cows with IMI in the first days after calving. The sensitivity/
specificity for detecting IMI with any pathogen were 46·5/
61·0% (DIM 1) to 56·7/56·2% (DIM 3) (Sargeant et al.
2001).
The collection of quarter foremilk samples was not started
until day 6, when all the cows yielded normal milk rather
than colostrum.
One aspect that has to be discussed in that context is
the difference between the results of the CMT and the SCC
of the quarter foremilk samples collected in the period
6–14 DIM, because differently from the CMT results in the
period 1–5 d after calving, the SCC between 6 and 14 d
post partum. The calving process and the metabolic
changes associated with the start of lactation are poten-
tially stressful and may predispose the cow to higher SCC
in the first days after calving as well as clinical mastitis if
invasion of mastitis pathogens has occurred during the dry
period. While the internal teat sealant does not affect the
immune system, it was designed to prevent or minimize
bacterial invasion of the teat and thus leads to lower SCC
in the first days after calving, resulting in significantly
better CMT results, and reduces the incidence of clinical
mastitis in early lactation. One can assume that after a cow
underwent the phase of colostrum with its high potential
for stress factors in connection with the calving process
accompanied with metabolic changes the SCC gets
normalized.
In the present study quarters that have received the
internal teat sealant in combinationwith a dry cowantibiotic
showed a significantly lower rate of clinical mastitis cases in
the first 100 d of lactation. An investigation concerning the
question of which pathogen caused the mastitis was not
realized.
Quarter foremilk samples collected between days 6 and
14 and 35 and 56 from cows of group AB had significantly
more positive cultures of Corynebacterium spp. than
samples collected in group AB+OS. In the present study
also other bacteria were reduced in group AB+OS, but
because of too small sample sizes the differences between
both groups were not significant.
However, the significance of Corynebacterium spp. as
natural inhabitants of the teat canal in relation to clinical
mastitis remains unclear. Le Van et al. (1985) showed that
intramammary infection of one quarter with C. bovis, even
when accompanied with an increased SCC, does not
affect milk yield significantly. Other workers speculated
that C. bovis has a protective effect against other mastitis
pathogens (Rainard & Poutrel, 1988; Lam et al. 1997).
Other studies revealed that quarters infected with
Corynebacterium spp. at drying off that remain untreated
are at increased risk of becoming infected with
Streptococcus uberis during the dry period (Woolford
et al. 2001; Berry & Hillerton, 2002a, b). The occurrence
of Str. uberis (as a main representative of the group of
aesculin-positive streptococci) has been associated with
new IMIs during the dry period (Bradley & Green, 2004),
especially on farms that use straw bedding. Str. uberis is
commonly identified in milk samples (Bramley, 1982).
Because clinical mastitis cases in the first 100 d of lactation
can be traced back to IMIs during the dry period (Bradley
& Green, 2000) optimal dry cow management involving
long-acting antibiotics and an internal teat sealant are
likely to reduce the use of intramammary antibiotics during
lactation. Mastitis during early lactation has considerable
economic impact and may adversely affect fertility (Schrick
et al. 2001). The use of an internal teat sealant is likely to
have the greatest impact in herds with mastitis problems
caused by environmental pathogens (mainly Str. uberis,
Escherichia coli and other coliforms) and in cows kept on
deep straw bedding. The internal teat sealant has also been
shown to be effective in preventing mastitis during early
lactation in cows with an extended dry period (Berry &
Hillerton, 2007).
Conclusion
The use of a commercial internal teal sealant combined with
routine long-acting dry cow antibiotics helps to decrease
IMIs caused by environmental pathogens during the dry
period. This results in a reduction in the number of cowswith
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clinical mastitis in early lactation and the use of antibiotics
during lactation.
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